Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.

Employees - 15, CEO - Paul V. Goode, Sector - Healthcare, Country - US, Market Cap -

Altman ZScore(max is 10): -63.28, Piotroski Score(max is 10): 2, Working Capital: $-761000, Total Assets: $4356000, Retained Earnings: $-156172000, EBIT: -17027000, Total Liabilities: $5207000, Revenue: $0

- Current Price $ - Analyst Target Price $